[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2002357561A1 - Oxazolidine derivative, methods of preparation and uses - Google Patents

Oxazolidine derivative, methods of preparation and uses

Info

Publication number
AU2002357561A1
AU2002357561A1 AU2002357561A AU2002357561A AU2002357561A1 AU 2002357561 A1 AU2002357561 A1 AU 2002357561A1 AU 2002357561 A AU2002357561 A AU 2002357561A AU 2002357561 A AU2002357561 A AU 2002357561A AU 2002357561 A1 AU2002357561 A1 AU 2002357561A1
Authority
AU
Australia
Prior art keywords
preparation
methods
oxazolidine derivative
oxazolidine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002357561A
Other versions
AU2002357561A8 (en
Inventor
Kaixian Chen
Yingjie Cui
Ruyun Ji
Yushe Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Materia Medica of CAS
Nanjing Changao Pharmaceutical Science and Technology Co Ltd
Original Assignee
Shanghai Institute of Materia Medica of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Materia Medica of CAS filed Critical Shanghai Institute of Materia Medica of CAS
Publication of AU2002357561A8 publication Critical patent/AU2002357561A8/en
Publication of AU2002357561A1 publication Critical patent/AU2002357561A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU2002357561A 2002-12-30 2002-12-30 Oxazolidine derivative, methods of preparation and uses Abandoned AU2002357561A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2002/000928 WO2004058732A1 (en) 2002-12-30 2002-12-30 Oxazolidine derivative, methods of preparation and uses

Publications (2)

Publication Number Publication Date
AU2002357561A8 AU2002357561A8 (en) 2004-07-22
AU2002357561A1 true AU2002357561A1 (en) 2004-07-22

Family

ID=32661062

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002357561A Abandoned AU2002357561A1 (en) 2002-12-30 2002-12-30 Oxazolidine derivative, methods of preparation and uses

Country Status (2)

Country Link
AU (1) AU2002357561A1 (en)
WO (1) WO2004058732A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1923388A4 (en) * 2005-08-12 2011-03-09 Takeda Pharmaceutical Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder
US7825122B2 (en) 2005-12-14 2010-11-02 Amgen Inc. Diaza heterocyclic sulfonamide derivatives and their uses
CN103450174B (en) * 2013-09-07 2015-04-08 吉首大学 Benzopyrone-phenyl-oxazolidone compounds as well as preparation methods and applications thereof
CN107365359B (en) * 2017-07-17 2021-06-04 昆明理工大学 Synthesis method of vancomycin chiral functional monomer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (en) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Oxazolidinones containing a substituted diazine moiety and their use as antimicrobials
AU698699B2 (en) * 1993-11-22 1998-11-05 Pharmacia & Upjohn Company Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
CN1288462A (en) * 1998-01-23 2001-03-21 法玛西雅厄普约翰美国公司 Oxazolidinone combinatorial libraries, compositions and method of prepn.
AU773359B2 (en) * 1999-07-28 2004-05-20 Pharmacia & Upjohn Company Oxazolidinones and their use as antiinfectives

Also Published As

Publication number Publication date
AU2002357561A8 (en) 2004-07-22
WO2004058732A1 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
AU2003248721A1 (en) Adsorbents, methods of preparation, and methods of use thereof
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003260342A1 (en) Spirobifluorene derivatives, their preparation and uses thereof
AU2003223207A1 (en) SCDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003236135A1 (en) Aralkyl-alcohol peiperazine derivatives and their uses as antidepressant
AU2003233010A1 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
EP1911757B8 (en) Method of preparation of 3-(1,3-Dihydroimidazole-2-thione-1-yl)-chromanes and thiochromanes as dopamine-beta-hydroxylase inhibitors
AU2003291668A1 (en) Sacrificial compositions, methods of use thereof, and methods of decomposition thereof
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003236527A1 (en) Compounds, compositions, and methods
AU2003265242A1 (en) Compounds, compositions, and methods
AU2003270015A1 (en) Compounds, compositions, and methods
AU2003299612A1 (en) Compounds, compositions and methods
AU2003301066A1 (en) Al2o3-la2o3-y2o3-mgo ceramics, and methods of making the same
AU2003224747A1 (en) Technetium-labeled rotenone derivatives, and methods of use thereof
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003265231A1 (en) Molecular actuators, and methods of use thereof
AU2003290507A1 (en) Compounds, compositions and methods
AU2003277079A1 (en) Compounds, compositions, and methods
AU2003297612A1 (en) 2-substituted-3-propenamide derivatives and methods of using the same
AU2002246950A1 (en) Hydrocapsules and method of preparation
AU2003267169A1 (en) Compounds, compositions and methods
AU2003300031A1 (en) Compounds, compositions, and methods
AU2002357561A1 (en) Oxazolidine derivative, methods of preparation and uses

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 18, NO 33, PAGE(S) 8694 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES, APPLICATION NO. 2002357561, UNDER INID (71) CORRECT THE NAME TO READ NANJING CHANG AO PHARMACEUTICAL SCIENCE AND TECHNOLOGY LIMITED COMPANY; SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase